Evidence map›Paper›PMID 33072713›Full record

ReviewFrontiers in public health2020

Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond.

Kuldeep Dhama, Shailesh Kumar Patel, Rakesh Kumar, Jigyasa Rana, Mohd Iqbal Yatoo, Akshay Kumar, Ruchi Tiwari, Jaideep Dhama, Senthilkumar Natesan, Rajendra Singh and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Research-Practice Partnership to Develop and Implement Routine Mental Health Symptom Tracking Tool Among Older Adults During COVID-19.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Kuldeep DhamaDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Shailesh Kumar PatelDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Rakesh KumarDepartment of Veterinary Pathology, Dr. G.C. Negi College of Veterinary and Animal Sciences, GSK Himachal Pradesh Agricultural University, Palampur, India.
Jigyasa RanaDepartment of Veterinary Anatomy, Faculty of Veterinary and Animal Sciences, Rajiv Gandhi South Campus Banaras Hindu University, Mirzapur, India.
Mohd Iqbal YatooDivision of Veterinary Clinical Complex, Faculty of Veterinary Sciences and Animal Husbandry, Sher-E-Kashmir University of Agricultural Sciences and Technology of Kashmir, Srinagar, India.
Akshay KumarDepartment of Cardiothoracic Surgery, Medanta Hospital, Gurgaon, India.
Ruchi TiwariDepartment of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, India.
Jaideep DhamaTara Hospital, New Delhi, India.
Senthilkumar NatesanIndian Institute of Public Health Gandhinagar, Gandhinagar, India.
Rajendra SinghDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
Harapan HarapanMedical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
Indian Veterinary Research Institute · INBanaras Hindu University · INChaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya · INIndian Institute of Public Health Gandhinagar · INSher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir · INSyiah Kuala University · IDUttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go-Anusandhan Sansthan · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic wreaked havoc worldwide, with more than 20 million confirmed cases and nearly 0. 75 million deaths as of 10th August 2020. Various factors determine the severity and symptoms of this infection. Older age and underlying diseases are the challenges being faced in controlling and treating COVID-19. In 2019, 703 million of the global population was older than 65 years of age. The estimated mortality due to COVID-19 in people older than 76 years of age is reportedly 18%. Frequent infections in older people, higher disease severity, and increased mortality are major challenges in the implementation of appropriate preventive measures and future strategies to protect against this disease in geriatric population. Poor health status, weak immune function, lowered organ function, increased probability of multiple underlying diseases, and poor attention to personal health can increase the susceptibility to various diseases in the geriatric population. Concerning inadequate immunity, the decrease expression of receptors and exaggerated pathophysiologic responses can be debilitating. However, future studies will reveal the hidden facets in these aspects in this COVID-19 catastrophe. In this article, we reviewed the main concerns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the geriatric population, including the risk of acquiring severe COVID-19 resulting in mortality, variation in clinical manifestations, and other pandemic-related concerns. We also discussed the need for increasing attention toward the elderly, taking appropriate prevention and control measures, and considering geriatric-related adjustments in vaccine design and development.

Indexed as

COVID-19PandemicsAgedAged, 80 and overHumansSARS-CoV-2COVID-19disease controlgeriatricsolder peoplepreventionSARS-CoV-2vaccines

Identifiers

PMID33072713
PMCPMC7536316
OpenAlexW3089254892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.